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Abstract
Two Pseudomonas strains, identified as closely related to Pseudomonas tolaasii, were isolated from milk of a farm with
frequent false-positive Delvotest results for screening putative antibiotic residues in raw milk executed as part of the
regulatory quality programme. Growth at 5 to 7uC of these isolates in milk resulted in high lipolysis and the production of
bacterial inhibitors. The two main bacterial inhibitors have a molecular weight of 1168.7 and 1140.7 Da respectively, are
heat-tolerant and inhibit Geobacillus stearothermophilus var. calidolactis, the test strain of most of the commercially available
microbiological inhibitor tests for screening of antibiotic residues in milk. Furthermore, these bacterial inhibitors show
antimicrobial activity against Staphylococcus aureus, Bacillus cereus and B. subtilis and also interfere negatively with yoghurt
production. Following their isolation and purification with RP-HPLC, the inhibitors were identified by NMR analysis as cyclic
lipodepsipeptides of the viscosin group. Our findings bring to light a new challenge for quality control in the dairy industry.
By prolonging the refrigerated storage of raw milk, the keeping quality of milk is influenced by growth and metabolic
activities of psychrotrophic bacteria such as pseudomonads. Besides an increased risk of possible spoilage of long shelf-life
milk, the production at low temperature of natural bacterial inhibitors may also result in false-positive results for antibiotic
residue screening tests based on microbial inhibitor assays thus leading to undue production loss.
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Introduction
Antibiotic residues in milk are of great concern to dairy farmers,
milk processors, authorities, and consumers because of public
health and industrial implications. In European countries,
inhibitory substances are routinely screened in farm milk samples
as part of a regulatory quality programme as required in
Regulation (EC) No 853/2004 [1] and its Corrigendum [2]. For
these purposes, microbiological inhibitory tests are widely used.
Their principle is traditionally based on the detection of growth
inhibition, indicated by clear inhibition zones in disc assays, or by
a colour change of the pH-indicator in the test medium. Many
commercial tests like the Delvotest, are based on the last principle
and use Geobacillus stearothermophilus var. calidolactis as test organism
and bromocresol purple as pH-indicator. Important drawbacks
with microbiological methods are the fact that the identity of the
inhibitory substance(s) is not revealed and the possible interference
by natural inhibitors.
Inhibitions without any reasonable explanation occur occasion-
ally and can have quite diverse origins, concisely reviewed
hereafter. Inhibitory substances other than antibiotics have been
reported in milk [3,4,5,6,7,8,9,10]. Especially colostrum and
mastitic milk are known to cause false-positive results in
microbiological assays for antibiotic residues [11,12,13,14,15].
Lactoferrin and lysozyme, two natural antibacterial substances
in milk, have been described to separately and synergistically have
an inhibitory effect on Geobacillus stearothermophilus var. calidolactis,
the most commonly used test organism in microbiological
inhibitor assays [16,17,18]. The antibacterial effect of the
lactoperoxidase/SCN-/H2O2 system and immunoglobulins is also
known [8,19]. The ability of some vitamin binding proteins to
inhibit the growth of bacterial species was suggested by Mullan
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[20]. Feed complemented with minerals, oligo-elements and
vitamins also appear to be a factor that may give rise to false-
positive results in the determination of antibiotics in milk with
Delvotest SP [21].
Along with the biochemical changes, the physical properties of
mastitic milk can also change. Milk with a pH above 7 due to a
strong inflammation of the udder and the concomitant transfer of
bicarbonate ions from blood to milk [22] can cause false-positive
results in microbiological assays based on acid production as
criterion for bacterial growth. High concentrations of alkaline
disinfecting products or detergents, due to inadequate rinsing and
draining, can also induce false-positive screening results
[23,24,25]. False-positive outcomes can also be induced by high
levels of antiparasitic agents or anti-inflammatory products
(unpublished data).
Several reports have suggested that the rate of false outcomes
increases with increasing somatic cell count (SCC) [26,27,28,29].
Non-proteinaceous inhibitors may be present in early lactation
and high SCC milk. In 1963, Stadhouders [30] associated the
inhibitory principle in raw milk against starter culture Streptococcus
cremoris with the fat globules. Due to the activity of indigenous milk
lipase or bacterial lipases [31], milk may contain high concentra-
tions of fatty acids, which may inhibit microbial inhibitor tests
[32,33] by their ability to kill or to inhibit the growth of bacteria
[34,35,31].
Pseudomonas spp., which are the most important spoilers of raw
milk, can produce heat-stable lipases [36]. A biologically
interesting lipid group in milk fat are the polar lipids, which are
mainly located in the milk fat globule membrane. In particular,
sphingolipids and their derivatives are considered highly bioactive
components possessing antibacterial activities [37]. The diapedesis
of neutrophils may lead to a leakage of serum components across
the mammary epithelium, which, in turn, could lead to lipolysis
and inhibitory action [33] and also to an increase in the electrical
conductivity of the milk due to an increase in sodium content [27].
Finally, high concentrations of milk protein and milk fat can
adversely affect antimicrobial residue test performance to a degree
that depends upon the analytical test method used [38]. Higher
concentrations of immunoglobulins and milk protein can also
cause false-positives with screening tests used on samples from
recently freshened heifers or cows [39]. Fat content of milk was
positively related to an increase in false-positive rates for the
Charm Blue Yellow II, Delvotest Accelerator, Delvotest T, Eclipse
50, and Eclipse 3G [29]. Low protein content may also cause false-
positive results, which could possibly be explained by the fact that
a minimum protein content is essential for normal growth of the
test organism [29].
Recently developed microbiological inhibitor tests show im-
proved detection capabilities for a broad range of antibiotics and
chemotherapeutics, allowing improved monitoring of the milk’s
compliance with regulatory requirements. However, an increased
rate of false-positive results with these tests has also been remarked
[29]. These can have serious consequences. First, good milk will be
discarded since in many cases raw milk is accepted or rejected
solely on the basis of a screening test. While subsequent analysis
may eventually reveal the causative agent, it cannot influence the
decision outcome given the time limitation for storage of raw milk.
Second, many countries worldwide will issue a financial penalty to
the defaulting farmer as part of the regulatory testing programme,
whenever a (false-) positive test result is obtained for inhibitory
substances. Recidivism can even result in a temporary interruption
of milk collection, leading to production and economic loss. Thus,
continued study of agents at the origin of such false positives holds
both scientific and economic benefit.
In this work, milk from two farms with frequent problems of
false-positive Delvotest MCS results for putative antibiotic residues
in the raw milk as part of the regulatory quality programme was
thoroughly examined. First analysis showed that no direct link
could be established to any of the known interfering parameters
described above. Therefore, we aimed to identify the cause of the
positive results, so that the farm management could be corrected,
the robustness of the microbiological inhibitor test improved and
the regulatory testing programme adapted.
Materials and Methods
Ethics statement
Since no specific animal experiments were involved in this
study, no Institutional Animal Care and Use Committee was
approached. For the purpose of this study raw milk was sampled
from two Belgian dairy farms. The private farms were owned by
Julius De Herdt in Berlaar, Belgium (coordinates: N 51u693.50599,
E 4u38920.61799) and Christian Simoens in Marquain, Belgium
(coordinates: N 50u36929.332, E 3u19928.301), respectively. Both
farmers, producing milk to be sold to dairies for the production of
dairy products, allowed sampling of raw cows’ milk from their
farm silo for the investigation of the putative presence of residues
of antibiotics in the farm milk. At one farm the farmer was helped
by ILVO to collect raw milk from eleven individual cows by
applying the standard cow milking protocol.
Milk sampling
Raw milk samples were aseptically collected from the farm
cooling tank of two Belgian farms with frequent problems of
occurrence of inhibitors in the milk despite no recent use of
antimicrobials. On one farm milk from each individual cow
(n= 11) was also sampled.
Raw milk, aseptically collected from four individual cows of a
farm in the neighbourhood of ILVO, was pooled and used as
reference milk ( = blank). The cows in mid-lactation were selected
on the basis of not being treated with veterinary drugs during the
last months and giving milk with a low number of somatic cells (,
26105 ml21). The blank milk was always checked on the presence
of antimicrobials before use with Delvotest MCS or Delvotest SP-
NT. In some experiments blank commercial full-cream UHT
consumption milk was used.
Antimicrobial testing by microbiological inhibitor tests
and receptor assays
For the detection of residues of antimicrobials in milk, following
antibiotic test kits were used: Delvotest SP-NT 5-PACK and
Delvotest MCS from DSM-Food Specialties (Delft, the Nether-
lands); Copan Milk Test microplates from DSM-Food Specialties;
PremiTest from DSM-Nutritional Products (Geleen, the Nether-
lands); Charm MRL Beta-lactam test, Charm II Sulfonamides
Milk, Charm II Tetracyclines Milk, Charm II Aminoglycosides
Milk, and Charm II Macrolides Milk were from Charm Sciences
Inc. (Lawrence, MA). The reagents were stored in a cool room at
462uC, except for the microbiological inhibitor tests that were
stored between 6 and 15uC.
Incubation of the tests (Plates of Delvotest SP-NT, Delvotest
MCS, Copan Milk Test, and ampoules of Premitest) took place in
a covered water bath (Type 19+ MP thermostat from Julabo
Labor-technic GmbH (Seelbach, Germany)) at 64.061uC. Geoba-
cillus stearothermophilus disc assays were incubated in an incubator
BD240 with natural convection from Binder GmbH (Tittlingen,
Germany) at 55.061uC.
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The colour interpretation of Delvotest SP-NT and Delvotest
MCS plates was done by means of a flatbed scanner (HP Scanjet
7400C, Hewlett-Packard Company, Palo Alto, CA) connected to
DelvoScan software, version 3.05 (DSM-Food Specialties). The
cut-off was set at a Z-value =23.00. A yellow colour of the agar
after incubation indicates no presence of inhibitory substances
(negative) and as a consequence a Z-value ,cut-off; when
inhibitors are present in the milk the colour of the pH-indicator
in the agar remains blue/purple, resulting in Z-values .23.00.
For the reading of Copan Milk Test plates a HP GRLYB-0307
flatbed scanner (Hewlett-Packard Company) connected to CScan
software, version 1.32 (Copan Italia S.p.A.) was used. The cut-off
was set at a CIF (Colour Impact Factor; yellow =0.1 and purple
= 10)-value = 4.5. The colour of PremiTest ampoules was
interpreted by means of a flatbed scanner (HP Scanjet 7400C,
Hewlett-Packard Company) connected to PremiScan software,
version 1.02 (DSM-Premitest B.V., Heerlen, the Netherlands).
The cut-off was set at a Z-value =24.50.
Reagents of Charm MRL Beta-lactam test were incubated in a
ROSA Incubator at 56uC (Charm Sciences Inc.). The strips were
interpreted by means of a ROSA Reader (Charm Sciences Inc.)
with a reader value = 0 as cut-off. Charm II reagents were
incubated in a Charm Inctronic 2 Dual Incubator (Charm
Sciences Inc.). The amount of bound radioactive tracer was read
with a liquid scintillation counter 1409 (Wallac, Waltham, MA).
The cut-off cpm for each type of test was set according to the
protocols provided by the reagents manufacturer.
All commercial microbial inhibitor tests were used following the
instructions of the kit manufacturers. In every run of each inhibitor
test, blank reference milk and antibiotic standards were included.
The p-aminobenzoic acid (A9878) was from Sigma-Aldrich
(Bornem, Belgium); the penicillinase (L037) was from Genzyme
(West Malling, UK). The disc assay was prepared and performed
as described by Ginn et al. [40]. For the disc assay an inhibition
zone around the filter disc of $2.0 mm is considered as positive.
Milk quality assessment
Determination of milk composition, somatic cell count,
and pH. The fat, protein and lactose content of the milk
samples was determined by Milcoscan 4000 (FOSS, Hillerød,
Denmark) and the somatic cell count (SCC) by Fossomatic 5000
(FOSS) at vzw Melkcontrolecentrum-Vlaanderen (Lier, Belgium).
A SevenMulti pH meter was used from Mettler-Toledo Inc.
(Columbus, OH) for pH-measurements. In Europe, the norm for
somatic cells is #46105 ml21; the criterion is applied on rolling
geometric averages (Corrigendum to Regulation (EC) No 853/
2004 [2]).
Total bacterial count, enumeration of psychrotrophic and
lipolytic bacteria. The total bacterial count and enumeration
of the psychrotrophic and fat splitting bacteria were performed on
Plate Count Agar (PCA, 3d at 30uC), Violet Red Bile Agar
(VRBA, 1d at 30uC), PCA (7d at 7uC), and Tributyrin Agar (TBA,
3d at 30uC), respectively, following ISO 4833 [41], ISO 4832 [42],
ISO 6730/IDF101 [43], and Method 3.32 [44], respectively. PCA
(CM0325), VRBA (CM0107), and TBA (PM0004) were from
Oxoid Limited (Basingstoke, UK). In Europe, the norm for raw
cows’ milk for total bacterial count is #105 cfu ml21; the criterion
is applied on rolling geometric averages (Corrigendum to
Regulation (EC) No 853/2004 [2]).
Determination of lipolysis, fat oxidation and
proteolysis. The lipolysis in milk was estimated as described
by Driessen et al. [45]. Therefore the milk fat was extracted
according to IDF Bulletin 265 [46] using the Bureau of Dairy
Industries (BDI)-reagent. Afterwards the free fatty acids were
titrated with NaOH and phenolphthalein as indicator according to
IDF Standard 6B [47]. The free fatty acids content is expressed as
mass% oleic acid 100 g21 fat. The peroxide value was determined
following AOAC Official Method 965.93 [48] and expressed in
meq O2 kg
21 fat. The proteolysis in milk was monitored following
an adaptation of the method described by Polychroniadou [49].
Isolation, characterization and identifications of
bacterial isolates. Two strains, Pseudomonas P866 and P867,
were isolated from the VRBA plates for the enumeration of the
number of coliforms in some raw milk samples. These strains were
purified, identified and conserved at 280uC in Protect vials
(International Medical Products, Brussels, Belgium).
Single colonies were streaked out on different selective media to
visualise enzymatic activities: Tributyrin Agar for lipolysis [44] and
PCA +2% UHT milk for the detection of proteolysis (FNZ
Method 53.27 [50]). The hemolytic activity was determined on
Blood Agar (BA) plates with addition of 5% of sheep blood as
described in ISO Standard 7932 [51]. Display of a clear halo
around the colony was considered as positive. Blood Agar Base
No 2 (BA, CM0271) and Sheep blood (SR0051) were from Oxoid
Limited. The ability to use lactose was checked by the isopropyl-b-
D-thio-galactoside-test (IPTG) [52].
Identification of the strains was done with API 20NE (20050)
from bioMe´rieux France (Craponne, France) and rpoB sequencing.
The rpoB gene was amplified as described previously by Ait Tayeb
et al. [53]. The PCR-amplified rpoB gene products were purified
using the Nucleofast 96 PCR system (Millipore, Billerica, MA). For
each sequence reaction a mixture was made using 3 ml purified
and concentrated PCR product, 1 ml of BigDye Termination RR
mix version 3.1 (Applied Biosystems, Carlsbad, CA), 1.5 ml of
BigDye buffer (56), 1.5 ml sterile milliQ water, and 3 ml
(20 ng ml21) of one of the sequencing primers. The amplification
primers were used as sequencing primers. The temperature-time
profile was as follows: 90 s at 94uC; 30 cycles of denaturation for
10 s at 94uC, primer annealing for 20 s at 45uC and extension for
50 s at 72uC; and a final extension of 5 minutes at 72uC. The
sequencing products were cleaned up as described previously [54].
Sequence analysis of the rpoB gene was performed using a 3100
DNA Sequencer (Applied Biosystems) according to protocols
provided by the manufacturer.
Phylogenetic analysis. Forward and reverse strands of rpoB
were assembled with the BioNumerics 4.6 software (Applied
Maths, Sint-Martens-Latem, Belgium) and were aligned with
sequences retrieved from the EMBL database using ClustalX [55].
Phylogenetic analyses were performed with Treecon [56]. Trees
were constructed with the neighbour joining algorithm without
corrections. Statistical evaluation of the tree topologies was
performed by bootstrap analysis with 1000 resamplings.
Growth and bacterial inhibitor production. Growth and
bacterial inhibitor production was followed in raw milk, full-cream
UHT milk, and Brain Heart Infusion Broth (BHI, CM1135,
Oxoid Limited). After inoculation with Pseudomonas P866 or P867,
the medium was incubated at 5–7 and 30uC with daily sampling
for enumeration of total bacterial count while the bacterial
inhibitor production was followed by Delvotest SP-NT, PremiT-
est, or on the disc assay with Geobacillus stearothermophilius var.
calidolactis. Bacterial inhibitor production of P. tolaasii LMG 2342T
in full-cream UHT milk was checked on Delvotest.
The production of bacterial inhibitor was also followed for pure
cultures of Pseudomonas P866 and P867, for P866 and P867 in
competition with raw milk flora, and for P867 in competition with
a mixture of 10 psychrotrophic Pseudomonas strains isolated from
Belgian raw milk samples.
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Bacterial inhibitor characterization assays
Estimation of the molecular weight. The molecular weight
of the bacterial inhibitor was tested by means of regenerated
cellulose dialysis membrane with a molecular weight cut-off
(MWCO) of 1 kDa (Spectra/Por Dialysis membrane 6 (132638)
from Spectrum Laboratories, Inc. (Rancho Dominguez, CA)).
Full-cream UHT milk was inoculated with Pseudomonas strain P867
and incubated for 24 h at 30uC. Dialysis of positive UHT milk
against blank raw milk was performed. Milk from the in- and
outside the dialysis membrane was sampled after 24 hours at 4uC
to be tested on Delvotest SP-NT.
Heat tolerance of bacterial inhibitor and fatty
acids. The heat tolerance of the bacterial inhibitor produced
by Pseudomonas P866 and P867 was tested by heating 5 ml of the
skimmed fraction of full-cream UHT milk after growth of the
bacteria in a glass test tube in a water bath at different
temperatures. After heating at 80, 90, or 100uC for 10 min, the
milk samples were rapidly cooled to 20uC with cold water and
tested on Delvotest SP-NT.
The interference and heat tolerance of free fatty acids on the
disk assay, Delvotest SP-NT and Copan Milk Test was tested by
spiking blank raw milk with 0.15% (w/v) of the following fatty
acids from Sigma-Aldrich: myristic (M3128), oleic acid (O1008),
palmitic (P0500), and stearic acid (S4751). Part of the doped milk
was preheated before testing.
Inhibition spectrum of the bacterial inhibitor. For
applications, not directly related to the disturbance of microbio-
logical inhibitor tests, the antimicrobial activity was tested against
following bacterial species: Bacillus cereus LMG 8221, Bacillus subtilis
LMG 7135T, Escherichia coli LMG 2092T, Geobacillus stearothermo-
philus var. calidolactis LMG 11163, Listeria monocytogenes ATTC
19110T, Pseudomonas fluorescens LMG 1794T, Salmonella Enteritidis
LMG 10396T, and Staphylococcus aureus LMG 8074.
BHI broth was inoculated with Pseudomonas strain P867,
incubated for 24 h at 30uC and filtered through a Millipak
0.22 mm Filter Unit (Millipore corporation). The inhibition
spectrum of the bacterial inhibitor produced was tested by placing
12.7 mm diameter filter discs (Antibiotic Test Discs,
FN0905A00005, Novolab, Geraardsbergen, Belgium) impregnat-
ed with 80 ml of filtrate on PCA plates, filled with 10 ml of agar
and inseminated with different bacterial strains. The plates were
incubated for 24 hours at 30uC, except for the plates with
Geobacillus stearothermophilus var. calidolactis, which were incubated
for 24 hours at 55uC.
Bacterial inhibitor isolation
For easy purification of the inhibitor substance, the isolated
strain was inoculated in Maximum Recovery Diluent (CM0733,
Oxoid Limited) and incubated for 3–4 days at 30uC, to ensure
maximal inhibitor production. The bacterial cells were removed
by centrifugation (20 minutes at 5,500 g).
For NMR identification of the inhibitor, Pseudomonas strain P867
was grown on Pseudomonas agar (PSA) plates (Oxoid, CM0559 +
CFC Selective Agar Supplement (Oxoid, SR103)) for 48 h at 30uC
for 48 h at 30uC. Cell material was collected in sterile distilled
water and pelleted by centrifugation (20 minutes at 5,500 g). Part
of the supernatans was, after addition of inhibitor-free milk
powder, tested on inhibitory characteristics on Delvotest T. The
remaining part of the cell-free supernatant was acidified; the
precipitate was obtained by centrifugation and twice washed as
described by Tran et al. [57]. The crude peptide mixture was
further purified by preparative RP-HPLC. Samples were dissolved
in Milli-Q water (Millipore Corporation) with pH adjusted to 8.0
with NaOH, until a concentration of 50 mg/ml was obtained.
Eight injections of 1 ml were performed on a Phenomenex column
(Luna C18(2) 250621.2 mm, 5 mm particle size) operating at a
flow rate of 17.5 ml/min. The ratio of the mobile phase solvents,
H2O (5 mM NH4OAc)/CH3CN was changed in a linear fashion
from 25:75 to 0:100 over a time span of 15 minutes. The major
compounds (1 and 4) were collected in two fractions (A and C)
following UV detection at l=214 nm. Some additional co-eluting
minor compounds (2 and 3) were collected in a third fraction (B).
Bacterial inhibitor characterization
Initial LC-MS data following extraction but prior to purifica-
tion, were collected with an Agilent 1100 Series HPLC with an
ESI detector type VL, equipped with a Phenomenex Inc.
(Torrance, CA) column (Luna C18(2), 25064.60 mm, 5 mm
particle size) The flow rate was 1 ml/min. The mobile phase
solvents, 5 mM ammonium acetate in water and acetonitrile, were
linearly changed from a 25:75 ratio to a 0:100 ratio over a time
span of 15 minutes. High-resolution mass spectra were recorded
on an Agilent 6220A time-of-flight mass spectrometer (Agilent,
Santa Clara, CA), equipped with an Agilent ESI/APCI multimode
source. The ionization mode was set to APCI (atmospheric
pressure chemical ionization), while the mass spectra were
acquired in 4 GHz high-resolution mode with a mass range set
to 3200 Da. NMR measurements on lipopeptide fractions A, B
and C were performed on respectively samples of 3.3 mg, 3.6 mg
and 5.7 mg dissolved in 600 ml DMF-d7 (Eurisotop, Saint Aubin,
France). NMR experiments were performed on either a Bruker
Avance II spectrometer (Bruker Biospin, Billerica, MA) operating
at 700.13 MHz and 176.05 MHz for 1H and 13C respectively and
equipped with a 5 mm 1H,13C,15N TXI-Z probe. Additional
measurements in acetone-d6 were executed to enable chemical
shift comparison with literature data of massetolide compounds.
These were performed on a Bruker Avance III spectrometer
operating at 500.13 MHz and 125.76 MHz for 1H and 13C
respectively, and equipped with a 5 mm 1HBBI-Z probe. The
sample temperature was set to 25uC throughout. 2D spectra
measured for structure elucidation include a 1H–1H gCOSY,
1H–1H TOCSY with a 90 ms MLEV–17 spinlock, a sensitivity-
improved, multiplicity edited, 1H–13C gHSQC applying adiabatic
180u pulses, a 1H–1H off-resonance ROESY with a 300 ms
spinlock and a 1H–13C gHMBC experiment optimized for a nJCH
coupling of 7 Hz. Standard pulse sequences as present in the
Bruker library were used throughout, except for the ROESY
where an in-house sequence was used. Typically, 2048 data points
were sampled in the direct dimension for 512 data points in the
indirect one, with the spectral width respectively set to 11 ppm
along the 1H dimension and 110 ppm (gHSQC) or 220 ppm
(gHMBC) along the 13C dimension. For 2D processing, the spectra
were zero filled to obtain a 204862048 real data matrix. Before
Fourier transformation, all spectra were multiplied with a squared
cosine bell function in both dimensions, except for the gCOSY
and gHMBC spectra where a squared sine bell was applied
together with magnitude calculation.
Inhibition by purified lipodepsipeptide fractions. Small
quantities of compounds isolated from fractions A, B and C were
freeze-dried and redissolved in a small quantity of raw milk and
tested (5 replicates) on Delvotest SP-NT to establish whether the
inhibitory characteristics are linked to the purified lipopeptides 1–4.
Results
Screening of milk for antibiotic residues
Milks sampled on two farms with frequent penalizations for
inhibitory substances in the farm silo milk tested (low) positive
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(presence of inhibitory substances) on Delvotest MCS, but negative
(absence of inhibitory substances) on Copan Milk Test, but with
higher CIF values than for blank milk samples. Even after pre-
heating the milk at 80uC for 10 min, removal of the fat after
centrifugation or addition of penicillinase or p-aminobenzoic acid
to the milk, still positive Delvotest MCS results were obtained. The
milk samples were further tested with Charm MRL Beta-lactam
test and Charm II assay for sulfonamides, tetracyclines, amino-
glycosides, and macrolides in milk, all with negative results. The
presence of antibiotic residues of the most important antibiotic
families could not be established.
The results of the second sampling of milk from each individual
cow (n= 11) and the farm silo (in duplicate) at farm 1 are
presented in Table 1. All individual cow milk samples tested
negatively on Delvotest MCS the day after sampling except for
cow 3, giving a borderline positive Z-value (20.24). This positive
result could be explained by the higher pH of the milk (7.06),
characteristic for subclinical mastitis, since the growth of Geobacillus
in the Delvotest is followed with bromocresol purple, a pH
indicator. The farm silo milk, sampled in duplicate, tested negative
that day, but the Z-values (23.32 and 3.47) were close to the cut-
off of 23.00 indicating some inhibition of the Delvotest test
organism Geobacillus stearothermophilus var. calidolactis. Retesting the
farm silo and individual cow milk samples, stored at 4uC, three
days after sampling, resulted in positive Delvotest MCS results for
the farm silo milk samples and the milk of cow 3 and 9. For the
milk of cows 4 and 7, borderline negative results were obtained. All
milk samples tested negative on Copan Milk Test (data not shown),
a more robust microbiological inhibitor test.
Assessment of milk quality
The farm silo milk samples were also analysed on composition
and quality. The somatic cell counts, 300,000 and 273,000 ml21,
respectively, were below the norm of 400,000 ml21 but above the
country average of 190,000 ml21. At 6.4 and 6.6, the pH values
were slightly lower than the average value for raw milk. The
content of free fatty acids was 1.8 and 3% of the fat (<0.15% of
the milk), respectively. These free fatty acid concentrations were
high for raw milk and may be indicative for the activity of bacterial
lipases. Both silo milk samples showed a normal proteolysis, and a
normal fat oxidation.
Analytical results of the second sampling of milk from each
individual cow (n= 11) and the farm silo (in duplicate) at farm 1
are presented in Table 1. High SCC above the norm of
46105 ml21 were measured in 6 out 11 individual cow milk
samples. A high level of free fatty acids was present in the milk of
cow 9 and in both farm silo milk samples.
Regarding the microbiological quality of the individual cow
milk samples, no extreme values were found for the total bacterial
count (40–16,000 cfu ml21), the number of coliforms (,1–29 cfu
ml21, data not shown), psychrotrophic (,10–2,000 cfu ml21, data
not shown), and fat splitting bacteria (,10–4,100 cfu ml21, data
not shown). The composition parameters fat, protein, and lactose
(data not shown) of the silo milk were normal.
Isolation, characterization and identification of strains
On VRBA plates, coliforms characteristically form dark red
colonies usually surrounded by a reddish zone with a granular
appearance by precipitation of bile salts. However, on some plates
some bacteria gave atypical results with a clear halo between the
colony and the reddish zone. P866 and P867 (rpoB sequence
accession numbers R-36630 and R-36631, respectively), isolated
as atypical bacterial strains from the VRBA plates with milk of cow
3 and 4 were purified and identified as Pseudomonas fluorescens with a
similarity level of 99.9% by using API 20NE. Since API
identification is limited in comparison to sequence-based identi-
fication [58], rpoB sequence analysis was performed. A phyloge-
netic clustering with all public available rpoB sequences from
members of the Pseudomonas genus indicated P. tolaasii LMG 2342T
as the closest relative for both strains (Figure 1).
The strains were able to grow at 7uC (psychrophilic) and did not
show any lipase activity using tributyrin as substrate. Both strains
showed a very strong hemolytic activity on blood agar plates; also
a proteolytic activity was detected. The P. tolaasii LMG 2342T
strain did not show any hemolytic activity, a finding in line with
the observations of Munsch and Alatossava [59] whom also
reported a non-haemolytic activity for a non-pathogenic variant of
P. tolaasii LMG 2342T.
None of the bacteria were able to hydrolyse lactose. The pH of
raw milk inoculated with Pseudomonas P867 dropped from 6.70 to
6.53 after 48 hours incubation at 30uC. Also fat oxidation was
observed in the inoculated milk incubated for 1 day at 30uC or for
4 days at 5uC (inoculated milk: 0.46 (at 30uC) and 1.08 (at 5uC)
meq O2 kg
21 fat; reference milk: 0.15 meq O2 kg
21 fat).
Growth and bacterial inhibitor production
The growth and inhibitor production of Pseudomonas strains
P866 and P867 inoculated in full-cream UHT milk were
monitored at 5uC, 7uC and also at 30uC. As could be expected,
both parameters were strongly influenced by the number of
bacteria in the inoculum. Even so, for a similar number of bacteria
inoculated, the growth and the bacterial inhibitor production were
not constant. An example for the growth of Pseudomonas strain
P867 incubated at 7uC is shown in Table 2.
Milk inoculated with P866 or P867 and incubated at 7uC,
needed 5 days and a high bacterial count to become positive on
Delvotest. Also in growth experiments at 30uC, a high number of
bacteria (.107 ml21) were needed before positive Delvotest results
could be generated (data not shown).
In most growth experiments the highest production of bacterial
inhibitor production was obtained in the stationary growth phase.
The Pseudomonas strains P866 and P867 do not need milk for
bacterial inhibitor production. A culture of Pseudomonas P866 and
P867 grown in BHI broth tested positively on PremiTest, a tissue
test comparable to the Delvotest.
Bacterial inhibitor characterization assays
In the dialysis experiments, milk with bacterial inhibitors by
growth of Pseudomonas strain P867 (Z-value = 10.77) inside the
dialysis membrane became negative on Delvotest SP-NT (Z-value
=25.60) after 24 hours dialysis at 4uC against blank raw milk;
while in the inverse dialysis blank raw milk (Z-value =26.68)
became positive on Delvotest SP-NT (Z-value = 8.08). The results
of the dialysis experiments show that the bacterial inhibitor is able
to permeate the 1 kDa dialysis membrane.
Heating of milk (5 min at 82uC or 10 min at 80uC) inactivates
natural inhibitors and is often applied to prove false-positive results
in microbial growth inhibition assays [60]. The bacterial inhibitors
produced by Pseudomonas P866 and P867 showed to be heat-stable
at 100uC for 10 min.
On Geobacillus disc assay plates, the culture of Pseudomonas strain
P867 in milk caused inhibition of the Gram-positive Bacillus cereus
LMG 8221, Geobacillus stearothermophilus var. calidolactis LMG
11163, Bacillus subtilis LMG 7135T, and Staphylococcus aureus
LMG 8074. No inhibition zones were found on the plates
inseminated with Listeria monocytogenes ATTC 19110T (Gram-
positive) or the Gram-negative Escherichia coli LMG 2092T,
Inhibitory Cyclic Lipodepsipeptides Produced by Pseudomonas spp.
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Figure 1. Phylogenetic analysis of the Pseudomonas isolates P866 and P867 on the basis of rpoB sequences. Unrooted neighbour joining
tree was based on partial rpoB sequences (1030 bp). Bootstrap values were generated from 1000 replicates of neighbour joining. Bootstrap values
higher than 50% are given.
doi:10.1371/journal.pone.0098266.g001
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Pseudomonas fluorescens LMG 1794T, or Salmonella Enteritidis LMG
10396T.
Isolation and identification of the bacterial inhibitor
LC-MS analysis of semi-purified extracts revealed the presence
of at least four compounds that could be separated in three
fractions: fraction A (compound 1, 1140.7 Da), fraction B (two co-
eluting minor compounds 2 and 3, 1154.7 Da each) and fraction
C (compound 4, 1168.7 Da) (Figures S1 and S2 in File S1).
Structure elucidation by NMR identified these compounds as four
similar cyclic lipodepsipeptides (CLPs), as discussed here in detail
for the fourth, most abundant compound.
The NMR 1D 1H spectrum (Figure S3 in File S1) and
resonance assignment (Table S1 in File S1) in DMF-d7 are
provided in the supporting information. Analysis of the charac-
teristic amino acid correlation patterns observed in the 2D 1H–1H
TOCSY spectrum of 4 (Figure S4 in File S1) revealed the presence
of three Leu, two Ile, two Ser, one Thr and one Glu. The
configuration is not further specified since the applied NMR
techniques only reveal the amino acid constitution. This is of
relevance since CLPs typically contain both L- and D-amino acids,
with variations in this respect between similar analogues (Figure 2).
Combined with the 1H–13C gHSQC spectrum, the presence of a
spin system corresponding to a linear 3-hydroxy fatty acid (FA)
moiety was also revealed. By following the sequential Ha-HN
cross-peaks in the 2D 1H–1H off-resonance ROESY spectrum
(Figure S5 in File S1), the NRC amino acid sequence and the FA
attachment could be established as FA-Leu1-Glu2-Thr3-Ile4-
Leu5-Ser6-Leu7-Ser8-Ile9. The 1H–13C gHMBC spectrum sub-
sequently allowed the assignment of most carbonyl 13C resonances
from the 2JCH coupling with the H
N resonances. Furthermore, the
existence of a correlation between the C-terminal Ile9 carbonyl
13C and the Thr3 Hb resonances in the HMBC spectrum and the
unusually high chemical shift value of the Thr3 Hb resonance [61]
indicates the presence of an ester bond between the C-terminal
carboxylic acid and the Thr3 hydroxyl groups (Figures S5 and S6
in File S1). Due to significant overlap of methylene groups in the
1H-13C HSQC, the length of the fatty acid chain could only be
deduced from the unaccounted part of the chemical formula
C56H99N9O16 obtained from HR-MS (Figure S7 in File S1). By
comparison with the known structural features at this point, the
fatty acid is identified as a 3-hydroxydodecanoic acid moiety
(HDDA), finalizing the constitutional structure elucidation.
Structural analysis of 1 was achieved in an analogous fashion
(Figures S8 and S9, Table S2 in File S1) and was found to differ
from 4 by the presence of 3-hydroxydecanoic acid (HDA) instead
of a HDDA moiety. The reduction in chain length with two
methylene units explains the 28 Da mass reduction compared to
4. As the minor CLPs 2 and 3 are co-eluting, NMR spectra could
only be measured on an approximately equimolar mixture. The
resonances of both compounds were insufficiently resolved to
unambiguously assign these to one particular peptide. However,
most of the 1H and 13C chemical shifts of both compounds were
practically identical to those of 4, while HR-MS data revealed
their chemical formula to be equal and 14 Da less compared to 4
(Figure S10 in File S1). Their characterisation was achieved
through direct comparison with the 2D spectra of 4. This reveals
one of the two compounds to possess an Ile4RVal4 substitution
and one an Ile9RVal9 substitution. Since the HR-MS data
suggests a loss of 14 Da for both 2 and 3 relative to 4, it appears
reasonable to assume the presence of a single Ile/Val substitution
in both 2 and 3. Thus, the sequences of 2 and 3 are most likely
C12-Leu1-Glu2-Thr3-Ile4-Leu5-Ser6-Leu7-Ser8-Val9 and C12-
Leu1-Glu2-Thr3-Val4-Leu5-Ser6-Leu7-Ser8-Ile9. Since spectral
complexity precludes extraction of the fatty acid chain length from
the NMR spectra, the alternative sequences C13-Leu1-Glu2-Thr3-
Val4-Leu5-Ser6-Leu7-Ser8-Val9 and C11-Leu1-Glu2-Thr3-Ile9-
Leu5-Ser6-Leu7-Ser8-Ile9 can presently not be excluded.
Finally, the purified compounds 1, 2+3 and 4 issued from
fractions A, B and C respectively, were reconstituted in blank raw
milk and tested on Delvotest SP-NT. The Z-values obtained were:
blank milk: -11.5560.64; fraction A: -0.5860.64; fraction B: -
1.8860.35 and fraction C: 1.9961.23 proving that the inhibitory
characteristics of each fraction can be lined to the purified
lipodepsipeptides.
Discussion
Microbiological inhibitor tests can generate false-positive results.
In the European residue legislation no maximum norm is fixed for
screening tests for the rate of false non-compliant results. Only
requirements for the rate of false compliant results are stipulated.
Following Commission Decision 2002/657/EC [62] this rate
should be ,5% (b-error) at the level of interest. In the same
Commission Decision, a general requirement for specificity states
that any valid method should be able to distinguish between the
analyte (antibiotic residue) and the other substances under the
experimental conditions used and that it is of prime importance
that interference, which might arise from matrix components, is
investigated. Finally, the same Commission Decision states that in
Table 2. Growth and bacterial inhibitor production by Pseudomonas strain P867 in full-cream UHT milk at 7uC.
Time Bacterial Delvotest SP-NT
(days) count (Z-value) result
(cfu ml21) mean SD
t = 0 7.06102 210.24 0.30 neg
t = 1 5.66105 210.10 0.14 neg
t = 2 1.66107 210.32 0.05 neg
t = 3 4.56107 29.19 0.01 neg
t = 4 1.36108 24.93 0.54 neg
t = 5 6.06107 2.18 1.07 pos
Delvotest cut-off Z-value =23.00. Delvotest results based on two replicates.
Notes: pos, positive; neg, negative.
doi:10.1371/journal.pone.0098266.t002
Inhibitory Cyclic Lipodepsipeptides Produced by Pseudomonas spp.
PLOS ONE | www.plosone.org 8 May 2014 | Volume 9 | Issue 5 | e98266
case a suspected non-compliant screening result is obtained, this
result should be confirmed by a confirmatory method. In practice
however, this is not always achievable, especially since raw milk
cannot be maintained in quarantine for the required time.
Therefore a decision about the fate of raw milk is generally based
on a screening test result.
Farm tank milk from two Belgian dairy producers, penalized on
several occasions because their milk tested positive for the presence
of antimicrobials in the Delvotest MCS at the milk control station,
was further studied. The dairy- and fieldmen of the two milk
producers could not explain the reason for the bulk tank failures
since no cows were treated during the preceding month nor had
fresh cows been added to the milking herd. The purpose of the
investigation was to establish whether antibiotic residues were
present in the positive samples and to indicate the origin of
inhibition by the silo milk. The results of the antimicrobial testing
using the Delvotest MCS after addition of penicillinase or p-
aminobenzoic acid to the milk, the Charm MRL Beta-lactam test
and the Charm II assay, were confirming the opinion of the dairy-
and fieldmen that the inhibition in the Delvotest was not caused by
the presence of residues of antibiotics or chemotherapeutics.
In most of the positive milk samples a high lipolysis was found.
This could be expected since a high SCC was found in the milk of
6 out of 11 cows. A high SCC could implicate an increased lipase
activity, both endogenic and bacterial, leading to a higher
concentration of short chain free fatty acids in this milk. An
inhibitory activity by some fatty acids is described in literature.
However, in our case there are several indications that the
inhibition of the Delvotest was not caused by fat destruction and
the release of fatty acids. Even when milk is spiked with high levels
of fatty acids that occur most abundantly in milk (myristic,
palmitic, stearic, and oleic acid) no inhibition of Geobacillus on the
disc assay could be observed (data not shown), while large
inhibition zones were obtained for the filter discs impregnated with
milk after Pseudomonas growth, even after dialysis through a 1 kDa
dialysis membrane.
From the VRBA plates with milk of cows 3 and 4, bacterial
strains, surrounded by a clear halo were isolated, purified, and
coded as P866 and P867. Both bacteria were identified as
Pseudomonas fluorescens to 99.9% confidence level by API 20NE. P.
tolaasii LMG 2342T was indicated as the closest relative by
phylogenetic clustering. The isolation of Pseudomonas strains is not
surprising. The current practices for the collection and storage of
the raw milk and the use of milking robots favor the growth of
psychrotrophic bacteria like Pseudomonas spp., which is able to grow
below 7uC [63,58,64,31]. Significant contaminations by pseudo-
monads occur due to inadequately sanitized surfaces of milking,
storage, and transporting equipment. Besides their rapid growth
ability in refrigerated milk, psychrotrophs produce heat-stable
extracellular proteases, lipases, and phospholipases. Pseudomonas
spp. are the primary concern with regard to lipolytic degradation
of milk fat [65]).
Pseudomonas spp. are also known to produce cyclic lipodepsipep-
tides. CLPs are composed of a fatty acid tail linked to a short
oligopeptide, which is cyclised to form a lactone (depsi) ring
between two amino acids in the peptide chain [66]. They are very
diverse both structurally and in terms of their biological activity
[67]. CLPs produced by Pseudomonas spp. play a key role in
antimicrobial activity against a range of other micro-organisms
[68,69]. Activity against Bacillus megaterium was shown for
corpeptins, syringopeptins, and tolaasin [70,71]. Besides an
antimicrobial activity, the CLPs cormycin A [72] and tolaasin
showed erythrocyte haemolytic properties [59]. The extracellular
CLP toxin, tolaasin, produced by P. tolaasii, is described as heat-
stable [73,74,75].
Both strains, P866 and P867, are psychrophilic, hemolytic, and
proteolytic. Inoculated milk incubated at 30uC or at 5–7uC
showed fat oxidation and tested positively on the Delvotest. In
comparison, P. tolaasii LMG 2342T showed no haemolytic activity
and a lower inhibitory effect. In all growth experiments, a high
number of bacteria (.107 ml21) was needed before positive
Delvotest results could be generated. These experimental findings
are contradictory to the initial false-positive Delvotest MCS results
at the milk control stations, generated by farm silo milk with a
normal bacterial count. Literature [76] suggests that the presence
of a bacterial biofilm could have an influence, or that quorum
sensing is regulating the production of inhibitory substances. For
example, the psychrotrophic bacterium Pseudomonas fluorescens uses
Figure 2. Structures of a selected number of known viscosin group CLPs and the obtained inhibitors with established molecular
constitution.
doi:10.1371/journal.pone.0098266.g002
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quorum sensing to coordinate the formation of biofilms,
exopolysaccharide production, and cell aggregation [77]. Perhaps
the bacterial flora in the milk is inhibited by such production of
antibacterial inhibitors, although the influence by a typical flora
present at the farm cannot be excluded. Preliminary experiments
with incubation of Pseudomonas inoculated in milk in the presence
of other pseudomonads or the normal flora of blank raw milk
showed no enhancement of bacterial inhibitor production but
more likely the opposite. Possibly the Pseudomonas P867 strain does
not produce toxins against other Pseudomonas strains.
The bacterial inhibitor by growth of Pseudomonas P867 in milk
was not only inhibitory to Geobacillus stearothermophilus var. calidolactis
but also to other Gram-positives (B. cereus, B. subtilis, and
Staphylococcus aureus) while the Gram-negatives tested were not
inhibited. Tolaasins also showed antimicrobial activity against
Gram-positive bacteria. Bassarello and co-workers [78] assayed
the antimicrobial activity of tolaasins A-E in comparison with
tolaasin I and II against the Gram-positive bacteria Bacillus
megaterium and Rhodococcus fascians, respectively, and the Gram-
negative bacteria Escherichia coli and Erwinia amylovora subsp.
carotovora. All the analogues, except tolaasin C, inhibited the
growth of the tested Gram-positive bacteria, although differences
among their specific activities were observed. However, none of
the tested Gram-negative bacteria were inhibited. The minimal
inhibitory quantity of tolaasin A to inhibit Bacillus megaterium was
1.28 mg [78].
The NMR analysis performed on the supernatant after
centrifugation of a culture of Pseudomonas P867 identified the
bacterial inhibitors as cyclic lipodepsipeptides. The four identified
CLPs possess structures that clearly define them as members of the
viscosin group [67] (Figure 2), a collection of CLPs with similar
oligopeptide sequences produced by Pseudomonas spp. These
compounds have been reported to display both antibiotic and
antifungal activities [79,80,81,82], likely by permeabilization of
the cellular membrane [81,83,84,85]. Until now, the observed
variations in molecular constitution within the viscosin group have
always been limited to residues at positions 2 (Glu or Gln), 4 (Ile,
Val or Leu) and 9 (Ile, Val or Leu) or affected the fatty acid chain
length (ranging from C10 to C12). The identified CLP structures 1–
4 thus fall within the known molecular space sampled by the
viscosin group. It should be noted that amongst these, only one
variation exists in terms of molecular configuration, i.e. at position
5, which is either an L-Leu or D-Leu, effectively dividing the
viscosin group into two subgroups. (Figure 2). Since no configu-
rational information was obtained for the isolated CLPs, their
exact identity and place within the viscosin group cannot be
established with full certainty. Known viscosin group members
with exactly the same constitution as 1 and 4 are either
massetolides A and C [80] or pseudophomines A and B [86,82].
A comparison of the 1H and 13C chemical shifts in acetone-d6
with those reported for the massetolides [80] clearly demonstrates
a significant difference at the level of the Leu5 residue. (Figure
S11, Tables S3 and S4 in File S1). On the other hand, comparing
the 1H and 13C chemical shifts in DMF-d7 solution with those of
WLIP [87,88], a CLP from the D-Leu5-subgroup, reveals a much
higher similarity for this residue. This provides a strong argument
for attributing 1–4 to the D-Leu5-subgroup. (Figure S12 in File
S1). It might therefore very well be that 1 and 4 correspond to
pseudophomin A and B respectively, CLPs with reported
antifungal activity produced by Pseudomonas fluorescens strain
BRG100. Nevertheless, differences in configurations at other
positions, most notably in the Ile4 and Ile9 side-chains cannot be
excluded. Therefore, the precise identity of these CLPs cannot be
established with full certainty.
Final conclusions
To our knowledge this paper is the first statement of
interference of microbial inhibitor tests for antibiotic residues in
milk by cyclic lipodepsipeptides produced by Pseudomonas strains.
The strains, isolated from milk of two farms with frequent
problems of false-positive Delvotest results were identified as
closely related to Pseudomonas tolaasii. Growth of the isolates in milk
not only resulted in high lipolysis of the raw milk, but also in the
production of heat-tolerant CLPs, shown to be members of the
viscosin group. The CLPs are inhibitory to Geobacillus stearothermo-
philus var. calidolactis, the test strain used in most of the
commercially available microbiological inhibitor tests. Interference
in the Delvotest, Eclipse, Charm Blue Yellow II, and PremiTest
was established, while the acid production in Copan Milk Test was
also hampered, but not to the same extent, resulting in no false
positive test results. The CLPs also showed antimicrobial activity
against Staphylococcus aureus, B. cereus, and B. subtilis.
Our findings have a serious consequence for regulatory quality
programmes. In such programmes, in most cases, a confirmation
of initial positive screening results is foreseen, including a heat-
treatment of the milk to exclude influence by natural inhibitors.
However, the bacterial inhibitors produced by Pseudomonas P866
and P867 are heat-stable and will in most test schemes lead to false
positive results. In some countries, special regulatory measures
including higher financial penalties or a suspension of milk
collection are imposed onto recidivists. Pseudomonads are known
to be well adapted for survival in milk processing environment, as
they are able to adhere strongly to the surface of milk processing
equipment and are capable to colonize the milking equipment and
storage tank at the farm. The production of bacterial inhibitors is
very likely to be a persistent problem on certain farms. We
speculate that they can occasionally produce enough inhibitors to
cause positive inhibitor test results.
It remains difficult to give a rate of occurrence of this
phenomenon. It is obvious, that in most cases positive inhibitor
tests are caused by the presence of residues of antibiotics, mainly
belonging to the family of b-lactams. Nevertheless, our data show
that results of microbiological inhibitor tests should be interpreted
with care, especially when the outcome of such tests is not
confirmed by a confirmatory method, providing full or comple-
mentary information enabling the substance to be unequivocally
identified.
Our findings indicate a new challenge for the dairy industry. By
extending the refrigerated storage of milk, the keeping quality of
milk is influenced by growth and metabolic activities of
psychrotrophic bacteria at low temperatures. This not only results
in possible spoilage of long-life milk and the production of yoghurt
of inferior quality, but also in false-positive microbial inhibitor
tests.
Supporting Information
File S1 File includes Figures S1–S12 and Tables S1–S4.
Figure S1: LC-MS chromatogram of the acidified mixture prior to
purification using UV-detection at 214 nm. The isolated fractions
are indicated with braces and the individual peptides with arrows.
Figure S2: Mass spectra of isolated lipopeptides 1–4 obtained
during LC-MS analysis of the extracted mixture prior to
purification. The range of detectable m/z values was limited to
1500 Da, ESI (Positive mode). Figure S3: 1D 1H spectrum of
peptide 4 in DMF-d7 solution, 25uC, 700 MHz. Figure S4: 2D
1H-1H TOCSY spectrum of peptide 4 in acetone-d6 solution,
25uC, 500 MHz, revealing the characteristic amino acid spin
system patterns. Figure S5: Established 1H-1H ROE contacts in
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peptide 4, observed in a 2D 1H-1H ROESY spectrum with 300 ms
mixing time in DMF-d7 solution. Figure S6: 3JCH contacts
between Thr3 Hb and carbonyl carbons of peptide 4, observed in
a 2D 1H–13C HMBC experiment, 25uC, 700 MHz, in DMF-d7
solution. Figure S7: High resolution mass spectrum of peptide 4.
Figure S8: 1D 1H spectrum of peptide 1 in DMF-d7 solution,
25uC, 700 MHz. A) HN region, B) Ha region and C) aliphatic
region spectrum. Figure S9: High resolution mass spectrum of
peptide 1. Figure S10: High resolution mass spectrum of peptides
2/3. Figure S11: A diagram plotting the 1H and 13C chemical
shifts of the CHa units of massetolide A (blue) from Gerard et al, J.
Nat. Prod. (1997) 60:223–229, and peptide 1 (red) in acetone-d6
solution recorded at 500 MHz, 25uC. The arrow indicates the
remarkable difference in chemical shift of the 5th residue,
suggesting a difference in configuration. Figure S12: Overlay of
2D 1H-13C HSQC spectra of peptide 1 (blue) and WLIP (red) in
DMF-d7 solution, recorded at 500 MHz, 25uC, CHa-region. The
similarity for the chemical shift of the Leu5 residue suggests the
milk peptides 1–4 belong to the D-subgroup of CLPs. Table S1:
1H and 13C NMR assignment of peptide 4 in DMF-d7 solution,
25uC, 700 MHz. Table S2: 1H and 13C NMR assignment of
peptide 1 in DMF-d7 solution, 25uC, 700 MHz. Table S3: 1H and
13C NMR assignment of peptide 1 in acetone-d6 solution, 25uC,
500 MHz. Table S4: 1H and 13C NMR assignment of peptide 4 in
acetone-d6 solution, 25uC, 500 MHz.
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